Total COVID-19 infections passes 10 million on Monday
The U.S. hit another grim milestone, surpassing 10 million COVID-19 infections on Monday, according to Johns Hopkins University.
Coronavirus vaccine
Pfizer says their COVID-19 vaccine prevented more than 90% of infections in a study
Pfizer announced Monday morning that their COVID-19 vaccine prevented more than 90% of infections in a study of volunteers, the most promising scientific advancement so far in the battle against the coronavirus.
Pfizer announces initial Phase 3 data showing its vaccine is likely effective; more safety data needed before FDA authorization
Pfizer’s ongoing late-stage clinical trial shows that the company’s vaccine is more effective at preventing COVID-19 than placebo.
Leader of Oxford vaccine trials “optimistic” that a vaccine could be revealed soon
The chief leading the Oxford vaccine trials is “optimistic” it could be ready “before Christmas.”
Federal government planning to pay for coronavirus vaccine for all Americans
The government is planning to pay for any future coronavirus vaccine for all Americans. The Centers for Medicare and Medicaid Services says it will pay for any vaccine authorized or approved by the Food and Drug Administration.
Pfizer expecting to apply for public use of coronavirus vaccine in late November
Pfizer says it expects to apply for public use of its coronavirus vaccine candidate in the third week of November, if everything goes according to plan. The emergency use authorization will be requested through the U.S. Food and Drug Administration.
Pfizer planning to start testing coronavirus vaccine on children
Drugmaker Pfizer is planning to start testing its experimental coronavirus vaccine on children as young as 12. The researcher leading the drug trial says parents have already expressed interest in enrolling their kids.
FDA push for volunteer follow-ups in clinical trials
The Administration says they want at least 2 months of data
Image: CNN (CNN)— The US Food and Drug Administration made clear Tuesday it will want to see two months of follow-up data after volunteers get their second dose of vaccine as part of clinical trials testing potential coronavirus vaccines. That would make it difficult, if not impossible, for any vaccine maker to apply for emergency use authorization by Election Day,…
